ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ERAS

Rosen Law Firm has filed a class action lawsuit against Erasca, Inc. on behalf of investors who purchased common stock between January 14, 2025 and April 26, 2026. The lawsuit alleges that Erasca and its executives made false and misleading statements about its lead oncology drug candidate ERAS-0015, including improper comparisons to a competing drug and undisclosed patent disputes. Investors who wish to serve as lead plaintiff must file by August 10, 2026.